Literature DB >> 3998709

Effect of chloroquine on African swine fever virus infection.

A Geraldes, M L Valdeira.   

Abstract

When present during the whole infective cycle, the lysosomotropic drug, chloroquine, inhibited cytopathic changes and production of African swine fever virus (ASFV) in Vero cells. This inhibition decreased when the drug was added from 1 h to 4 h after infection. Chloroquine had no effect on the virus nor on viral adsorption and internalization. Electron microscopy showed that, in the presence of the drug, the virions were retained in large vacuoles having a lysosomal appearance. This inhibition was fully reversible, even when the drug was removed as late as 72 h after infection. The results support the hypothesis that ASFV enters the cells by adsorptive endocytosis and not by fusion with the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3998709     DOI: 10.1099/0022-1317-66-5-1145

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Evidence for an acid phosphatase in African swine fever virus.

Authors:  M L Valdeira; M C Duque-Magalhães; A Geraldes
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Small rho GTPases and cholesterol biosynthetic pathway intermediates in African swine fever virus infection.

Authors:  Jose I Quetglas; Bruno Hernáez; Inmaculada Galindo; Raquel Muñoz-Moreno; Miguel A Cuesta-Geijo; Covadonga Alonso
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

3.  Inhibition of African swine fever virus in cultured swine monocytes by phosphonoacetic acid (PAA) and by phosphonoformic acid (PFA).

Authors:  F Villinger; E V Genovesi; D J Gerstner; T C Whyard; R C Knudsen
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  New agents active against African swine fever virus.

Authors:  A Sola; S Rodríguez; C Gil-Fernández; B Alarcón; M E González; L Carrasco
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

5.  African swine fever virus uses macropinocytosis to enter host cells.

Authors:  Elena G Sánchez; Ana Quintas; Daniel Pérez-Núñez; Marisa Nogal; Susana Barroso; Ángel L Carrascosa; Yolanda Revilla
Journal:  PLoS Pathog       Date:  2012-06-14       Impact factor: 6.823

6.  Aggresomes resemble sites specialized for virus assembly.

Authors:  C M Heath; M Windsor; T Wileman
Journal:  J Cell Biol       Date:  2001-04-30       Impact factor: 10.539

7.  Phytochemical analysis and in-vitro anti-African swine fever virus activity of extracts and fractions of Ancistrocladus uncinatus, Hutch and Dalziel (Ancistrocladaceae).

Authors:  Folorunso O Fasina; Oyinlola O Olaokun; Olusola O Oladipo; Margaret M Fasina; Adesoji A Makinde; Livio Heath; Armanda D S Bastos
Journal:  BMC Vet Res       Date:  2013-06-19       Impact factor: 2.741

8.  African Swine Fever Virus Undergoes Outer Envelope Disruption, Capsid Disassembly and Inner Envelope Fusion before Core Release from Multivesicular Endosomes.

Authors:  Bruno Hernáez; Milagros Guerra; María L Salas; Germán Andrés
Journal:  PLoS Pathog       Date:  2016-04-25       Impact factor: 6.823

Review 9.  Mechanisms of Entry and Endosomal Pathway of African Swine Fever Virus.

Authors:  Elena G. Sánchez; Daniel Pérez-Núñez; Yolanda Revilla
Journal:  Vaccines (Basel)       Date:  2017-11-08

Review 10.  Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century.

Authors:  Jean-Marc Rolain; Philippe Colson; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2007-07-16       Impact factor: 5.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.